Search This Blog

Wednesday, March 11, 2026

Insulet positive EVOLUTION 2 feasibility results for fully closed-loop Omnipod

 

Insulet reports positive EVOLUTION 2 feasibility results for fully closed-loop Omnipod in adults with type 2 diabetes

  • Company plans pivotal EVOLVE trial of the Omnipod closed-loop system in 2026.
  • Insulet targets a 510(k) submission for the Omnipod closed-loop system in 2027.
  • Commercial launch of the fully closed-loop Omnipod system for type 2 diabetes targeted in 2028.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)